POST-COVID CONDITION
Clinical trials for POST-COVID CONDITION explained in plain language.
Never miss a new study
Get alerted when new POST-COVID CONDITION trials appear
Sign up with your email to follow new studies for POST-COVID CONDITION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could metformin or colchicine ease long COVID? major trial launches
Disease control ENROLLING_BY_INVITATIONThe RECLAIM trial is testing whether two inexpensive, widely available drugs—metformin (a diabetes medication) and colchicine (a gout medication)—can improve quality of life for people with long COVID. The study will enroll 1,250 adults in the Netherlands who have had persistent …
Matched conditions: POST-COVID CONDITION
Phase: PHASE3 • Sponsor: Janneke van de Wijgert • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a pill ease long COVID fatigue? new trial hopes to find out
Symptom relief OngoingThis phase 2a trial tests whether the drug abrocitinib can reduce severe fatigue in adults with Long COVID. About 46 people who were never hospitalized for COVID but now have long-term fatigue will take either 50 mg, 100 mg of abrocitinib, or a placebo daily for 12 weeks. Researc…
Matched conditions: POST-COVID CONDITION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC